Table 1.
Characteristics of the included studies conducted in Ethiopia on patients delay in Tuberculosis diagnosis
| First author (publication year) |
Region | Data collection period | Study population | Sample size | Prolonged delay classification (days) | Response rate | Median (IQR) | Prolonged delay (%) |
|---|---|---|---|---|---|---|---|---|
| Adenager et al. (2017) [28] | Addis Ababa |
April to June 2012 |
Both SP and SN PTB patients | 422 | > 21 | 99.76% | 17 (9–33) | 42.1% |
| Alema et al. (2019) [16] | Tigray |
Nov. 1, 2015 to Jan.30, 2016 |
new PTB patients | 422 | > 30 | 30 (21–60) | ||
| Asefa et al. (2014) [29] | SNNPR | June to December 2012 | SPPTB patients | 328 | > 30 | NR | 30 (20.2–60) | NR |
| Asres et al. (2017) [17] | Amhara | April 8 to July 7, 2013 | All newly diagnosed TB patients | 605 | > 30 | 100% | 45 (3–425) | 53.4% |
| Asres et al. (2019) [18] | SNNPR |
January to December 2015 |
all new SP, SN and EPTB cases |
735 | > 25 | NR | 25 (15–36) | NR |
| Belay et al. (2012) [30] | Afar | September 2009 and March 2010 |
TB patients |
216 | > 20 | 78% | 20 (8–60) | 76% |
| Bogale et al. (2017) [31] | Amhara | February to May, 2016 | PTB cases | 296 | NR | NR | Mean, 33.9(sd = 14) | NR |
| Demissie et al. (2002) [32] | Addis Abeba | August 1 to December 311,998 | Newly PTB patients | 700 | > 30 | NR | 60 | NR |
| Fuge et al. (2018) [9] | SNNRP |
May and September, 2016 |
TB patients | 398 | > 21 | 99.3 | 30 (5–120)* | 58.2% |
| Gebeyehu et al. (2014) [10] | Amhara | January to April, 2013 | SP, SN and EPTB | 376 | > 21 | NR |
SP27(10–59) SN 30 (9–65) |
NR |
| Gebreegziabher et al. (2016) [19] | Amhara | Oct 2013 to Oct 2014. | All new PTB patients | 706 | > 30 | NR | 18 (8–34) | NR |
| Getnet et al. (2019) [11] | Somali | between December 2017 and October 2018 | All PTB patients | 442 | > 30 | NR |
For cases:50 (40–72) For controls: 20 (14–25) |
48.87% |
| Hussen et al. (2012) [8] | Oromiya |
February to March 2011 |
All pulmonary TB patients | 129 | > 14 | 96% |
63 (14–896)* * = range |
NR |
| Mekonnen et al. (2014) [22] | Amhara | 10 March – 08 May 2012 | TB patients | 315 | NR | NR |
30 (3–270)* * = range |
52.4% |
| Mesfin et al. (2005) [33] | Tigray | NR | TB patients | 237 | > 21 | NR |
SPPTB:90 SNPTB:60 EXTB:90 |
NR |
| Seid et al. (2018) [34] | Amhara | April1, 2016 to January 30, 2017 | TB patients | 382 | > 30 | NR | 30 (15–60) | 41% |
| Shiferaw et al. (2019) [35] | Amhara | 01 to 30 December 2017 | All TB patients | 170 | > 21 | 95.3% | Mean: 53.2 (± 8.54). | 59.9% |
| Tsegaye et al. (2016) [12] | Amhara | July 1 to September 30, 2013 | All PTB patients | 528 | > 30 | 99.1% | 36 (36) | 62.3% |
| Wondimu et al. (2007) [13] | Oromiya |
January 11, 2006 to April 11, 2006 |
All PTB patients | 201 | NR | 99.5% | 28 | NR |
| Yarlagadda et al. (2018) [36] | Oromiya | February 9 to 20/2015 | All PTB patients | 105 | > 21 | NR | 91 (mean) | 58.09% |
| Yimer et al. (2005) [37] | Amhara | September 1, 2003 and December 31, 2003 | new smear positive PTB patients | 384 | > 30 | NR | 30 (15–90) | NR |
| Yimer et al. (2014) [14] | Amhara | January to August 2010 | All PTB patients | 201 | > 30 | NR | 21 (7–60] | 68.7% |
| Yirgu et al. (2017) [20] | Oromiya | June to July 2014 | All PTB patients | 358 | > 14 | 100% | 15 (5–30) | |
| Zeleke et al. (2014) [15] | SNNR | March 2013 to February 2014 | SPPTB patients | 221 | > 35 | 98.6% | 35 | NR |
SNNRP Southern nations, nationalities, and peoples’ region, NR Not Report, SPPTB Smear positive pulmonary tuberculosis, SN smear negative, EPTB extra pulmonary tuberculosis
* = P < 0.05 (The 95%CI does not include one)